Cargando…
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model
INTRODUCTION: Substantial preclinical evidence has indicated that inhibition of integrin linked-kinase (ILK) correlates with cytotoxic/cytostatic cellular effects, delayed tumor growth in animal models of cancer, and inhibition of angiogenesis. Widely anticipated to represent a very promising therap...
Autores principales: | Kalra, Jessica, Warburton, Corinna, Fang, Karen, Edwards, Lincoln, Daynard, Tim, Waterhouse, Dawn, Dragowska, Wieslawa, Sutherland, Brent W, Dedhar, Shoukat, Gelmon, Karen, Bally, Marcel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716491/ https://www.ncbi.nlm.nih.gov/pubmed/19409087 http://dx.doi.org/10.1186/bcr2252 |
Ejemplares similares
-
Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK)
por: Santos, Nancy Dos, et al.
Publicado: (2007) -
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
por: Kalra, J, et al.
Publicado: (2010) -
The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck
por: Eke, Iris, et al.
Publicado: (2009) -
New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis
por: McDonald, Paul C., et al.
Publicado: (2022) -
Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes
por: Wu, Chuanyue, et al.
Publicado: (2001)